These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2723134)
21. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Fava M; Evins AE; Dorer DJ; Schoenfeld DA Psychother Psychosom; 2003; 72(3):115-27. PubMed ID: 12707478 [TBL] [Abstract][Full Text] [Related]
23. The double-blind in danger: untoward consequences of informed consent. Brownell KD; Stunkard AJ Am J Psychiatry; 1982 Nov; 139(11):1487-9. PubMed ID: 6753613 [TBL] [Abstract][Full Text] [Related]
24. Time-blind evaluation of psychopathology in drug research. Bobon DP Acta Psychiatr Belg; 1978; 78(4):635-45. PubMed ID: 362829 [TBL] [Abstract][Full Text] [Related]
25. Blinding, unblinding, and the placebo effect: an analysis of patients' guesses of treatment assignment in a double-blind clinical trial. Moscucci M; Byrne L; Weintraub M; Cox C Clin Pharmacol Ther; 1987 Mar; 41(3):259-65. PubMed ID: 3816016 [TBL] [Abstract][Full Text] [Related]
26. Medication guesses in double-blind studies. Rickels K Am J Psychiatry; 2010 Sep; 167(9):1128-9; author reply 1129. PubMed ID: 20826862 [No Abstract] [Full Text] [Related]
27. [How blind is a double-blind trial really? Validity of controlled investigations]. Modestin J; Hodel J Int Pharmacopsychiatry; 1977; 12(3):129-36. PubMed ID: 334685 [TBL] [Abstract][Full Text] [Related]
28. Inert placebo versus active medication. Patient blindability in clinical pharmacological trials. Bystritsky A; Waikar SV J Nerv Ment Dis; 1994 Sep; 182(9):485-7. PubMed ID: 8083675 [TBL] [Abstract][Full Text] [Related]
29. How blind is double-blind? A study of fish oil versus placebo. Damico KE; Stoll AL; Marangell LB; Cohen BM Prostaglandins Leukot Essent Fatty Acids; 2002 Apr; 66(4):393-5. PubMed ID: 12054908 [TBL] [Abstract][Full Text] [Related]
30. Assessing clinical trials- double-blind trials. Gore SM Br Med J (Clin Res Ed); 1981 Jul; 283(6284):122-4. PubMed ID: 6789934 [No Abstract] [Full Text] [Related]
32. Psychopharmacology of temper outbursts. A review. Mattes JA J Nerv Ment Dis; 1986 Aug; 174(8):464-70. PubMed ID: 3525749 [TBL] [Abstract][Full Text] [Related]
33. Mental handicap and double-blind trial design. Dark R; Rogers E Br J Psychiatry; 1987 Nov; 151():705-7. PubMed ID: 3328639 [No Abstract] [Full Text] [Related]
34. The ACTH (4-9) analog ORG 2766 in panic disorder: a preliminary study. den Boer JA; Westenberg HG; Mastenbroek B; van Ree JM Psychopharmacol Bull; 1989; 25(2):204-8. PubMed ID: 2557650 [No Abstract] [Full Text] [Related]
35. Double blind: double talk or are there ways to do better research. Ney PG; Collins C; Spensor C Med Hypotheses; 1986 Oct; 21(2):119-26. PubMed ID: 3641026 [TBL] [Abstract][Full Text] [Related]
36. Double-blind versus deceptive administration of a placebo. Kirsch I; Weixel LJ Behav Neurosci; 1988 Apr; 102(2):319-23. PubMed ID: 3365327 [TBL] [Abstract][Full Text] [Related]
37. How study design affects outcomes in comparisons of therapy. I: Medical. Colditz GA; Miller JN; Mosteller F Stat Med; 1989 Apr; 8(4):441-54. PubMed ID: 2727468 [TBL] [Abstract][Full Text] [Related]
38. [Scientific methodology and psychopharmacology]. Elie R; Ohayon M Ann Med Psychol (Paris); 1992; 150(2-3):192-4; discussion 194-5. PubMed ID: 1343517 [No Abstract] [Full Text] [Related]
39. Use of Placebo in Clinical Trials of Psychotropic Medication. Hasnain M; Rudnick A; Bonnell WS; Remington G; Lam RW Can J Psychiatry; 2018 May; 63(5):338-341. PubMed ID: 29668328 [TBL] [Abstract][Full Text] [Related]
40. Double-blind assessment of therapeutic efficacy in clinical trials. Cohen S Dig Dis Sci; 1983 Jun; 28(6):564-5. PubMed ID: 6861586 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]